A Pilot Study To Evaluate The Preliminary Safety And Feasibility Of The Materna Medical Device (NCT02332759) | Clinical Trial Compass
CompletedNot Applicable
A Pilot Study To Evaluate The Preliminary Safety And Feasibility Of The Materna Medical Device
United States61 participantsStarted 2014-07
Plain-language summary
The Materna device aims to prevent pelvic tissue damage by preventing overstretching of pelvic floor muscle fibers during delivery. The device is a single use, disposable, mechanical dilator that penetrates the first 4 cm or ½ of the vaginal canal and gradually expands the vagina from a resting diameter of 2-3 cm to the fully expanded size of a delivering fetus, roughly 8-10 cm. The Materna device will be used during the first stage of labor, for roughly 1-2 hours, in a hospital Labor and Delivery unit, under the supervision of trained clinical labor and delivery providers
Who can participate
Age range18 Years – 64 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Primiparas, or previous pregnancy terminated before 24 weeks gestation
* Single fetus birth
* Subject is able to understand the risks and potential benefits of participating in the study and is willing to provide written informed consent
* Subject is willing and able to comply with specified follow-up evaluations
* Planned to have epidural during birthing process
Exclusion Criteria:
* Previous delivery, or previous pregnancy beyond 24 weeks gestation
* Less than 36 weeks gestation
* Neurological diseases e.g. Multiple Sclerosis that may result in unrelated pelvic disorders
* Muscular or skin disorder that effects elasticity of tissue such as scleroderma or lupus
* Local or systemic infection e.g. HIV, herpes
* Diabetes
* Clinically estimated fetal weight \> 4,500 grams
* Any prior surgical procedures to the vaginal anatomy which could lead to pelvic dysfunction, pelvic fractures, or pelvic soft tissue injuries. Evaluated during baseline screening
* High likelihood of less than 1 hour of potential device dilation time after the woman arrives at the center and receives epidural
* A cervical dilation of greater than or equal to 6 cm
* BMI \> 32.5 prior to becoming pregnant